Guinea-Bissau vs Mauritania: Population requiring preventive chemotherapy for schistosomiasis
Guinea-Bissau
399,321
in 2024
Mauritania
596,151
in 2024
Guinea-Bissau rank
41st
Mauritania rank
38th
Population requiring preventive chemotherapy for schistosomiasis over time
- Guinea-Bissau
- Mauritania
How they compare
Mauritania currently reports 596,151 against 399,321 in Guinea-Bissau, a difference of 196,830.
That makes Mauritania's figure about 1.5 times Guinea-Bissau's.
Across all 15 years both countries report, Mauritania has been ahead every year.
Guinea-Bissau ranks 41st and Mauritania ranks 38th of 52 countries.
Mauritania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 219,316 | 706,396 | 487,080 | Mauritania |
| 2020s | 221,684 | 849,983 | 628,299 | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Guinea-Bissau or Mauritania?
- Mauritania, at 596,151 against 399,321 in Guinea-Bissau as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Guinea-Bissau and Mauritania?
- 196,830, with Mauritania ahead.
- How many years of comparable data are there for Guinea-Bissau and Mauritania?
- 15 years are reported by both, from 2010 to 2024.
- How do Guinea-Bissau and Mauritania rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Guinea-Bissau ranks 41st and Mauritania ranks 38th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.